PV pharm branch, vendor, cage 0U9U0

This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) vehicle to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), valued at $18,070.38 with a firm fixed price structure. The award was made on October 20, 2025, by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military healthcare systems. The contract represents a child order under the company's broader SPE2DX IDC with DLA Troop Support, a $999,999,999.00 prime vendor agreement running through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. This delivery order was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal contract portfolio with the Defense Logistics Agency, supplying critical pharmaceutical commodities including brand-name and generic medications, vaccines, medical devices, and specialty healthcare products across multiple therapeutic domains to support military and veteran healthcare systems. The company's proven capability to fulfill federal medical supply requirements through competitive procurement, demonstrated through numerous delivery orders ranging in value, positions it as a key vendor for the Defense Health Agency and other government healthcare entities. The upcoming Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to expand this partnership structure through multiple regional awards with multiple contractors, further solidifying AmerisourceBergen's role in the military's medical supply chain infrastructure.